相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Population pharmacokinetics of levofloxacin, gatifloxacin, and moxifloxacin in adults with pulmonary tuberculosis
Charles A. Peloquin et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2008)
Cost-effectiveness of empirical prescribing of antimicrobials in community-acquired pneumonia in three countries in the presence of resistance
Monique Martin et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2007)
Antibiotic treatment of community acquired pneumonia varies widely across Germany
Yvonne Kohlhammer et al.
JOURNAL OF INFECTION (2007)
Moxifloxacin vs amoxicillin/clavulanate in the treatment of acute sinusitis
Jose R. Arrieta et al.
AMERICAN JOURNAL OF OTOLARYNGOLOGY (2007)
Molecular characterization of increasing fluoroquinolone resistance in Streptococcus pneumoniae isolates in Canada, 1997 to 2005
Heather J. Adam et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2007)
Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults
Lionel A. Mandell et al.
CLINICAL INFECTIOUS DISEASES (2007)
Efficacy and safety of 3-day azithromycin versus 5-day moxifloxacin for the treatment of acute bacterial exacerbations of chronic bronchitis
Marcus Zervos et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2007)
Clinical efficacy of moxifloxacin in the treatment of exacerbations of chronic bronchitis: a systematic review and meta-analysis
Marc Miravitlles et al.
ARCHIVOS DE BRONCONEUMOLOGIA (2007)
Eradication of H-influenzae in AECB:: A pooled analysis of moxifloxacin phase III trials compared with macrolide agents
M. S. Niederman et al.
RESPIRATORY MEDICINE (2006)
Long-term moxifloxacin in complicated tuberculosis patients with adverse reactions or resistance to first line drugs
Luigi Ruffo Codecas et al.
RESPIRATORY MEDICINE (2006)
Randomized controlled trial of moxifloxacin compared with piperacillin-tazobactam and amoxicillin-clavulanate for the treatment of complicated intra-abdominal infections
Mark A. Malangoni et al.
ANNALS OF SURGERY (2006)
Moxifloxacin versus ethambutol in the first 2 months of treatment for pulmonary tuberculosis
William J. Burman et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2006)
Eradication of common pathogens at days 2, 3 and 4 of moxifloxacin therapy in patients with acute bacterial sinusitis
Horacio Ariza et al.
BMC EAR NOSE AND THROAT DISORDERS (2006)
Antibiotic treatment and factors influencing short and long term outcomes of acute exacerbations of chronic bronchitis
R Wilson et al.
THORAX (2006)
Community-acquired pneumonia recovery in the elderly (CAPRIE): Efficacy and safety of moxifloxacin therapy versus that of levofloxacin therapy
A Anzueto et al.
CLINICAL INFECTIOUS DISEASES (2006)
Real-life treatment of acute exacerbations of chronic bronchitis with moxifloxacin or macrolides - A comparative post-marketing surveillance study in general practice
T. Schaberg et al.
CLINICAL DRUG INVESTIGATION (2006)
Treatment with sequential intravenous or oral moxifloxacin was associated with faster clinical improvement than was standard therapy for hospitalized patients with community-acquired pneumonia who received initial parenteral therapy
T Welte et al.
CLINICAL INFECTIOUS DISEASES (2005)
Guidelines for the management of adult lower respiratory tract infections
M Woodhead et al.
EUROPEAN RESPIRATORY JOURNAL (2005)
Pharmacodynamics of moxifloxacin and levofloxacin simulating human serum and lung concentrations
S Schubert et al.
INFECTION (2005)
A randomized trial comparing the cardiac rhythm safety of moxifloxacin vs levofloxacin in elderly patients hospitalized with community-acquired pneumonia
J Morganroth et al.
CHEST (2005)
Sequential intravenous/oral moxifloxacin versus intravenous piperacillin-tazobactam followed by oral amoxicillin-clavulanate for the treatment of complicated skin and skin structure infection
P Giordano et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2005)
Moxifloxacin for the treatment of acute exacerbations of chronic obstructive pulmonary disease
S Sethi
CLINICAL INFECTIOUS DISEASES (2005)
Clinical implications of pharmacokinetics and pharmacodynamics of fluoroquinolones
B Wispelwey
CLINICAL INFECTIOUS DISEASES (2005)
Mechanisms of resistance to quinolones
GA Jacoby
CLINICAL INFECTIOUS DISEASES (2005)
The quinolones: Past, present, and future
VT Andriole
CLINICAL INFECTIOUS DISEASES (2005)
Broader distribution of plasmid-mediated quinolone resistance in the United States
A Robicsek et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)
Susceptibility to moxifloxacin of pneumococci isolated in English hospitals participating in the European Antimicrobial Resistance Surveillance System (EARSS) in 2003
AP Johnson et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2005)
Efficacy and tolerability of sequential intravenous/oral moxifloxacin therapy in pneumonia - Results of the first post-marketing surveillance study with intravenous moxifloxacin in hospital practice
J Barth et al.
CLINICAL DRUG INVESTIGATION (2005)
Retrospective analysis of the safety profile of oral moxifloxacin in elderly patients enrolled in clinical trials
VT Andriole et al.
DRUG SAFETY (2005)
Clinical experience with moxifloxacin in patients with respiratory tract infections
GA Faich et al.
ANNALS OF PHARMACOTHERAPY (2004)
Short-term and long-term outcomes of moxifloxacin compared to standard antibiotic treatment in acute exacerbations of chronic bronchitis
R Wilson et al.
CHEST (2004)
Early bactericidal activity of moxifloxacin in treatment of pulmonary tuberculosis: a prospective, randomized study
MWR Pletz et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2004)
Issues in pharmacokinetics and pharmacodynamics of anti-infective agents:: Kill curves versus MIC
M Mueller et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2004)
Safety profile of oral and intravenous moxifloxacin: Cumulative data from clinical trials and postmarketing studies
P Ball et al.
CLINICAL THERAPEUTICS (2004)
Moxifloxacin and glucose homeostasis - A pooled-analysis of the evidence from clinical and postmarketing studies
JR Gavin et al.
DRUG SAFETY (2004)
Moxifloxacin-containing regimens of reduced duration produce a stable cure in murine tuberculosis
EL Nuermberger et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2004)
Prevalence of mupirocin resistance in clinical isolates of Staphylococcus aureus and Staphylococcus epidermidis:: Results of the Antimicrobial Resistance Surveillance Study of the Paul-Ehrlich-Society for Chemotherapy, 2001
M Kresken et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2004)
Once-daily moxifloxacin therapy for community-acquired pneumonia in general practice - Evidence from a post-marketing surveillance study of 1467 patients
H Koch et al.
CLINICAL DRUG INVESTIGATION (2004)
Daily-practice treatment of acute exacerbations of chronic bronchitis with moxifloxacin in a large cohort in Germany
H Koch et al.
CLINICAL DRUG INVESTIGATION (2004)
Efficacy and tolerability of moxifloxacin in patients with sinusitis treated in general practice - Results of a post-marketing surveillance study
W Elies et al.
CLINICAL DRUG INVESTIGATION (2004)
Emergence of a fluoroquinolone-resistant strain of Streptococcus pneumoniae in England
AP Johnson et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2003)
Sequential IV/PO moxifloxacin treatment of patients with severe community-acquired pneumonia
H Lode et al.
RESPIRATORY MEDICINE (2003)
An economic evaluation of sequential IV/po moxifloxacin therapy compared to IV/po co-amoxidav with or without clarithromycin in the treatment of community-acquired pneumonia
MF Drummond et al.
CHEST (2003)
Antibiotic resistance among gram-negative bacilli in US intensive care units - Implications for fluoroquinolone use
MM Neuhauser et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2003)
Molecular characterization of fluoroquinolone resistant Streptococcus pneumoniae clinical isolates obtained from across Canada
GG Zhanel et al.
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE (2003)
In vitro activity of moxifloxacin, levofloxacin, gatifloxacin and linezolid against Mycobacterium tuberculosis
JC Rodríguez et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2002)
Randomized controlled trial of sequential intravenous (i.v.) and oral moxifloxacin compared with sequential i.v. and oral co-amoxiclav with or without clarithromycin in patients with community-acquired pneumonia requiring initial parenteral treatment
R Finch et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2002)
Moxifloxacin - In uncomplicated skin and skin structure infections
RBR Muijsers et al.
DRUGS (2002)
Increasing resistance of Streptococcus pneumoniae to fluoroquinolones:: results of a Hong Kong multicentre study in 2000
PL Ho et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2001)
Mutant prevention concentrations of fluoroquinolones for clinical isolates of Streptococcus pneumoniae
JM Blondeau et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2001)
A comparison of the safety and efficacy of moxifloxacin (BAY 12-8039) and cefuroxime axetil in the treatment of acute bacterial sinusitis in adults
R Siegert et al.
RESPIRATORY MEDICINE (2000)
分享论文
